Cargando…
New formulation of an old drug in hypertension treatment: the sustained release of captopril from cyclodextrin nanoparticles
Captopril (CAP) was the first angiotensin I-converting enzyme (ACE) inhibitor to be developed and is widely used in hypertension treatment. On the other hand, cyclodextrins (CDs) are cyclic oligosaccharides whose cone-shaped cavity allows formation of noncovalent inclusion complexes with appropriate...
Autores principales: | de Azevedo, Mariangela de Burgos M, Tasic, Ljubica, Fattori, Juliana, Rodrigues, Fábio HS, Cantos, Fabiana C, Ribeiro, Leandro P, de Paula, Vanice, Ianzer, Danielle, Santos, Robson AS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124386/ https://www.ncbi.nlm.nih.gov/pubmed/21720512 http://dx.doi.org/10.2147/IJN.S18999 |
Ejemplares similares
-
Formulation, evaluation and optimization of sustained release matrix tablets of captopril
por: Pandya, V. Pandya, et al.
Publicado: (2012) -
Poly(3-hydroxi-butyrate-co-3-hydroxy-valerate) (PHB-HV) microparticles loaded with holmium acetylacetonate as potential contrast agents for magnetic resonance images
por: de Azevedo, Mariangela de Burgos M, et al.
Publicado: (2019) -
Development and Characterization of Orally Disintegrating Tablets Containing a Captopril-Cyclodextrin Complex
por: Musuc, Adina Magdalena, et al.
Publicado: (2020) -
Intestine-Specific, Oral Delivery of Captopril/Montmorillonite: Formulation and Release Kinetics
por: Madurai, Suguna Lakshmi, et al.
Publicado: (2010) -
Formulation and Characterisation of a Combination Captopril and Hydrochlorothiazide Microparticulate Dosage Form
por: Chikukwa, Mellisa T. R., et al.
Publicado: (2020)